BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2693348)

  • 1. [Second line chemotherapy of carcinoma of the ovary. Current approaches].
    Sesti F; Mantenuto L; Ciancaglini G; Zupi E; Terenzi S; Piccione E
    G Ital Oncol; 1989; 9(4):121-4. PubMed ID: 2693348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adjuvant and first line chemotherapy of carcinoma of the ovary. Current approaches].
    Sesti F; Mantenuto L; Ciancaglini G; Zupi E; Araco P; Piccione E
    G Ital Oncol; 1989; 9(4):113-6. PubMed ID: 2693346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy of carcinoma of the endometrium. Current approaches].
    Sesti F; Mantenuto L; Silvestri C; Terenzi S; Viotto L; Piccione E
    G Ital Oncol; 1989; 9(2-3):59-62. PubMed ID: 2670761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of carcinoma of the cervix uteri. Current approaches].
    Sesti F; Mantenuto L; Ciancaglini G; Araco P; De Santis L; Piccione E
    G Ital Oncol; 1989; 9(4):125-8. PubMed ID: 2693349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of carcinoma of the vulva and vagina. Current approaches].
    Sesti F; Ciancio F; Bancheri C; Iannarilli P; Silvestri C; Piccione E
    G Ital Oncol; 1989; 9(4):117-20. PubMed ID: 2693347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal chemotherapy for ovarian carcinoma.
    Markman M
    Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments.
    Kyrgiou M; Salanti G; Pavlidis N; Paraskevaidis E; Ioannidis JP
    J Natl Cancer Inst; 2006 Nov; 98(22):1655-63. PubMed ID: 17105988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intraperitoneal chemotherapy in ovarian carcinoma].
    Piura B
    Harefuah; 2001 Sep; 140(9):844-9, 894, 893. PubMed ID: 11579736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
    Tropé C; Kaern J; Vergote I
    Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
    [No Abstract]   [Full Text] [Related]  

  • 12. [High-dose chemotherapy in advanced epithelial ovarian cancer].
    Curé H; Bay JO; Plagne R; Chollet P; Dauplat J
    Bull Cancer; 2001 Sep; 88(9):842-51. PubMed ID: 11604356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy in epithelial ovarian cancer.
    Wang J; Li AJ; Karlan BY
    Curr Womens Health Rep; 2002 Feb; 2(1):20-6. PubMed ID: 12112979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraperitoneal chemotherapy for ovarian cancer].
    Noma J; Yoshida N
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
    Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
    Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ovarian carcinoma: various aspects of intraperitoneal chemotherapy].
    Los G; Beijnen JH; Dubbelman R; ten Bokkel Huinink WW; McVie JG
    Ned Tijdschr Geneeskd; 1988 Jul; 132(29):1347-50. PubMed ID: 3412503
    [No Abstract]   [Full Text] [Related]  

  • 17. [Consensus and new development in epithelial ovarian cancer chemotherapy in 1995].
    Hatae M; Onishi Y; Maeda Y; Nakamura T; Maeda T; Wada T
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1182-9. PubMed ID: 7661570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal chemotherapy.
    Markman M
    Semin Oncol; 1991 Jun; 18(3):248-54. PubMed ID: 2042064
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy for ovarian cancer: an evidence-based approach.
    Geisler JP; Manahan KJ; Wiemann MC
    Minerva Ginecol; 2004 Dec; 56(6):539-45. PubMed ID: 15729206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.